Latest filing published 18 Jul 2012 for Protalix BioTherapeutics, Inc..
Insider track record
No signal scores available.
Einat Brill Almon: trading record in brief
All filings by Einat Brill Almon on record concern Protalix BioTherapeutics, Inc. In total, 27 filings cover trades dated from 11 May 2008 to 16 July 2012.
The open-market record consists of 13 sales worth €2.6M, with no purchase. The rest of the record consists of 5 share grants and 9 option exercises. So far in 2012, the count stands at no purchases and 1 sale.
On 18 July 2012 came the latest disclosure, a share grant in Protalix BioTherapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Einat Brill Almon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 185,000 shares0Common StockSEC:0001144204-12-039996:0
- 116,848 shares@ US$0.972Common StockSEC:0001144204-12-026344:0
- 166,848 shares@ US$7.13Common StockSEC:0001144204-12-026344:2
- 35,000 shares@ US$9.02Common StockSEC:0001209191-10-049624:0
- 20,000 shares@ US$9.08Common StockSEC:0001209191-10-049624:1
- 15,000 shares@ US$9.29Common StockSEC:0001209191-10-049624:2
- 70,000 shares@ US$0.972Common StockSEC:0001209191-10-049624:3
- 27,500 shares@ US$8.00Common StockSEC:0001209191-10-045450:0
- 22,500 shares@ US$8.16Common StockSEC:0001209191-10-045450:1
- 4,740 shares@ US$0.399Common StockSEC:0001209191-10-045450:2
- 45,260 shares@ US$0.972Common StockSEC:0001209191-10-045450:3
- 28,000 shares@ US$9.39Common StockSEC:0001209191-09-049181:0
- 23,680 shares@ US$9.39Common StockSEC:0001209191-09-049181:1
- 38,320 shares@ US$9.43Common StockSEC:0001209191-09-049181:2
- 93,954 shares@ US$0.399Common StockSEC:0001209191-09-049181:3
- 3,954 shares@ US$9.48Common StockSEC:0001209191-09-049181:4
- 44,000 shares@ US$5.13Common StockSEC:0001209191-09-036037:0
- 11,000 shares@ US$4.95Common StockSEC:0001209191-09-036037:1
- 59,822 shares@ US$0.399Common StockSEC:0001209191-09-036037:2
- 4,822 shares@ US$4.95Common StockSEC:0001209191-09-036037:3
- 44,707 shares@ US$0.399Common StockSEC:0001209191-09-027626:0
- 4,707 shares@ US$3.79Common StockSEC:0001209191-09-027626:1
- 40,000 shares@ US$4.00Common StockSEC:0001209191-09-027626:2
- 48,370 shares@ US$0.398Common StockSEC:0001385116-08-000002:0
- 6,943 shares@ US$2.78Common StockSEC:0001385116-08-000002:1
25 of 26 declarations
